These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The use of antiviral agents during an (impending) influenza pandemic]. Opstelten W, van Steenbergen JE, van Essen GA, Van der Sande MA. Ned Tijdschr Geneeskd; 2007 May 05; 151(18):1008-12. PubMed ID: 17508684 [Abstract] [Full Text] [Related]
3. [Neuraminidase inhibitors in prophylaxis and treatment of influenza]. Nitsch-Osuch A, Brydak LB, Wardyn AK. Pol Merkur Lekarski; 2008 Jul 05; 25(145):67-73. PubMed ID: 18839619 [Abstract] [Full Text] [Related]
5. Influenza: evolving strategies in treatment and prevention. Lynch JP, Walsh EE. Semin Respir Crit Care Med; 2007 Apr 05; 28(2):144-58. PubMed ID: 17458769 [Abstract] [Full Text] [Related]
6. The risk of seasonal and pandemic influenza: prospects for control. Monto AS. Clin Infect Dis; 2009 Jan 01; 48 Suppl 1():S20-5. PubMed ID: 19067611 [Abstract] [Full Text] [Related]
10. [New influenza A (H1N1) pandemia and cancer patients: what do we do?]. Barrière J, Otto J, Cua E, Coindard G, Peyrade F. Bull Cancer; 2009 Nov 15; 96(11):1045-52. PubMed ID: 19822486 [Abstract] [Full Text] [Related]
11. Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza. Zhang H. J Antimicrob Chemother; 2008 Aug 15; 62(2):219-23. PubMed ID: 18238888 [Abstract] [Full Text] [Related]
13. Seasonal influenza: an overview. Li C, Freedman M. J Sch Nurs; 2009 Feb 15; 25 Suppl 1():4S-12S. PubMed ID: 19197008 [Abstract] [Full Text] [Related]
14. [Influenza vaccine: globalization of public health stakes]. Collin N, Briand S. Med Trop (Mars); 2009 Aug 15; 69(4):322. PubMed ID: 19725377 [Abstract] [Full Text] [Related]
15. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. Abed Y, Baz M, Boivin G. J Infect Dis; 2009 Jan 15; 199(2):180-3. PubMed ID: 19046066 [Abstract] [Full Text] [Related]
16. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza. Magano J. Chem Rev; 2009 Sep 15; 109(9):4398-438. PubMed ID: 19537777 [No Abstract] [Full Text] [Related]
17. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 Nov 13; 58(44):1241-5. PubMed ID: 19910912 [Abstract] [Full Text] [Related]
18. [Influenza A (H1N1): proposed guideline for hospital management of confirmed or suspected cases]. Capozzi C, Panà A, Dipartimento di Sanità Pubblica. Ig Sanita Pubbl; 2009 Nov 13; 65(2):139-56. PubMed ID: 19529045 [Abstract] [Full Text] [Related]
19. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Smith JR, Sacks S. Int J Clin Pract; 2009 Apr 13; 63(4):596-605. PubMed ID: 19335705 [Abstract] [Full Text] [Related]